Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Michael Yaron to Treatment Outcome

This is a "connection" page, showing publications Michael Yaron has written about Treatment Outcome.

 
Connection Strength
 
 
 
0.087
 
  1. Wigler I, Grotto I, Caspi D, Yaron M. The effects of Zintona EC (a ginger extract) on symptomatic gonarthritis. Osteoarthritis Cartilage. 2003 Nov; 11(11):783-9.
    View in: PubMed
    Score: 0.019
  2. Elkayam O, Ben Itzhak S, Avrahami E, Meidan Y, Doron N, Eldar I, Keidar I, Liram N, Yaron M. Multidisciplinary approach to chronic back pain: prognostic elements of the outcome. Clin Exp Rheumatol. 1996 May-Jun; 14(3):281-8.
    View in: PubMed
    Score: 0.011
  3. Wigler I, Elkayam O, Paran D, Yaron M. Spa therapy for gonarthrosis: a prospective study. Rheumatol Int. 1995; 15(2):65-8.
    View in: PubMed
    Score: 0.010
  4. Tishler M, Brostovski Y, Yaron M. Effect of spa therapy in Tiberias on patients with ankylosing spondylitis. Clin Rheumatol. 1995 Jan; 14(1):21-5.
    View in: PubMed
    Score: 0.010
  5. Tishler M, Caspi D, Yaron M. Long-term experience with low dose methotrexate in rheumatoid arthritis. Rheumatol Int. 1993; 13(3):103-6.
    View in: PubMed
    Score: 0.009
  6. Paran D, Kidron D, Mayo A, Ziv O, Chowers Y, Caspi D, Yaron M, Paran H. Somatostatin analogue treatment attenuates histological findings of inflammation and increases mRNA expression of interleukin-1 beta in the articular tissues of rats with ongoing adjuvant-induced arthritis. Rheumatol Int. 2005 Jun; 25(5):350-6.
    View in: PubMed
    Score: 0.005
  7. Lidar M, Elkayam O, Goodwin D, Yaron M, Caspi D. Protracted Mycobacterium kansasii carpal tunnel syndrome and tenosynovitis. Isr Med Assoc J. 2003 Jun; 5(6):453-4.
    View in: PubMed
    Score: 0.005
  8. Paran D, Elkayam O, Mayo A, Paran H, Amit M, Yaron M, Caspi D. A pilot study of a long acting somatostatin analogue for the treatment of refractory rheumatoid arthritis. Ann Rheum Dis. 2001 Sep; 60(9):888-91.
    View in: PubMed
    Score: 0.004
  9. Caspi D, Elkayam O, Eisinger M, Vardinon N, Yaron M, Burke M. Clinical significance of low titer anti-nuclear antibodies in early rheumatoid arthritis: implications on the presentation and long-term course of the disease. Rheumatol Int. 2001 Feb; 20(2):43-7.
    View in: PubMed
    Score: 0.004
  10. ElKayam O, Yaron M, Caspi D. From wheels to feet: a dramatic response of severe chronic psoriatic arthritis to etanercept. Ann Rheum Dis. 2000 Oct; 59(10):839.
    View in: PubMed
    Score: 0.004
  11. Elkayam O, Paran D, Yaron M, Caspi D. Polymyalgia rheumatica in patients with ankylosing spondylitis: a report of 5 cases. Clin Exp Rheumatol. 1997 Jul-Aug; 15(4):411-4.
    View in: PubMed
    Score: 0.003
  12. Elkayam O, Yaron M, Zhukovsky G, Segal R, Caspi D. Toxicity profile of dual methotrexate combinations with gold, hydroxychloroquine, sulphasalazine and minocycline in rheumatoid arthritis patients. Rheumatol Int. 1997; 17(2):49-53.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)